AGXT Antikörper (AA 183-392)

Produktnummer ABIN6136660

Produktdetails anti-AGXT Antikörper

Target: AGXT (Alanine Glyoxylate Aminotransferase (AGXT))

Bindungsspezifität: AA 183-392

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser AGXT Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Sequenz: DSVASLGGTP LYMDRQGIDI LYSGSQKALN APPGTSLISF SDKAKKKMYS RKTKPFSFYL DIKWLANFWG CDDQPRMYHH TIPVISLYSL RESLALIAEQ GLENSWRQHR EAAAYLHGRL QALGLQLFVK DPALRLPTVT TVAVPAGYDW RDIVSYVIDH FDIEIMGGLG PSTGKVLRIG LLGCNATREN VDRVTEALRA ALQHCPKKKL

Kreuzreaktivität: Human

Produktmerkmale: Polyclonal Antibodies

Aufreinigung: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 183-392 of human AGXT (NP_000021.1).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB,1:500 - 1:2000,IHC,1:50 - 1:200

Kommentare:

HIGH QUALITY

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu AGXT

Target: AGXT (Alanine Glyoxylate Aminotransferase (AGXT))

Andere Bezeichnung: AGXT (AGXT Produkte)

Hintergrund: This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria.,AGXT,AGT,AGT1,AGXT1,PH1,SPAT,SPT,TLH6,Signal Transduction,Endocrine & Metabolism,Amino acid metabolism,AGXT

Molekulargewicht: 43 kDa

Gen-ID: 189

UniProt: P21549

Pathways: Monocarboxylic Acid Catabolic Process, Dicarboxylic Acid Transport